2
744
K. Kacprzak, B. Gierczyk / Tetrahedron: Asymmetry 21 (2010) 2740–2745
0
0
All shifts were referenced to the internal tetramethylsilane. 1D gra-
dient selected NOESY spectra were recorded using a standard se-
quence from Bruker sequences library, mixing time (d8) was set
to 0.300 s; 256–512 scans were collected.
J = 9.2, 2.7 Hz, H-7 ), 7.39 (d, 1H, J = 4.4 Hz, H-3 ), 7.29 (d, 1H,
0
J = 2.7 Hz, H-5 ), 6.03 (ddd, 1H, J = 17.3, 10.4, 7.1 Hz, H-10), 5.22
(bd, 1H, J = 6.3 Hz, H-9), 5.13 (dt, 1H, J = 10.4, 1.4 Hz, H-11b), 5.10
(dt, 1H, J = 17.3, 1.4 Hz, H-11a), 3.95 (s, 3H, H-11 ), 3.20 (pseudoq,
0
Mass spectra were recorded on a AMD 604/402, IR spectra (KBr
pellets) were recorded on a Brucker ITS 113v spectrometer. Optical
rotation was measured using Perkin–Elmer LS-30 spectropolarim-
eter. Cache Worksystem Pro 5 (Fujitsu) and GAUSSIAN 4.0 (Gauss-
1H, J = 8.4 Hz, H-8a), 2.95 (ddd, 1H, J = 14.3, 7.9, 2.2 Hz, H-2a),
2.89 (dd, 1H, J = 14.3, 9.9 Hz, H-2b); 2.84 (m, 1H, H-6b), 2.75 (m,
1H, H-6a), 2.26 (m, 1H, H-3), 1.87 (dd, 1H, J = 13.9, 9.7 Hz, H-7b),
13
1.87 (m, 1H, H-4), 1.56 (m, 2H, H-5a,b), 1.52 (m, 1H, H-7a).
C
2
6
0
0
0
ian) was used for the molecular modeling.
NMR (CDCl
3
): 158.11 (C-6 ), 147.58 (C-2 ), 144.93 (C-4 ), 142.15
0
0
0
0
(
C-9 ), 140.23 (C-10), 132.09 (C-8 ), 127.13 (C-10 ), 121.72 (C-7 ),
0
0
4
.2. General procedure for the synthesis of 9-azido-(9-deoxy)-
119.39 (C-3 ), 114.83 (C-11), 101.16 (C-5 ), 65.10 (br, C-9), 58.58
0
Cinchona alkaloids by the substitution of the corresponding 9-
O-mesylates (Method A)
(C-8), 55.64 (C-11 ), 49.86 (C-6), 48.71 (C-2), 39.70 (C-3), 27.87
23 5
(C-4), 26.33 (C-5), 24.19 (C-7); HRMS (EI) calcd for C20H N O
ꢁ1
3
49.1903, found 349.1899, IR (KBr)
1588, 1473, 1450, 1259, 1228, 1133, 1088, 1032, 850, 830;
= +28.0 (c 1, CHCl ).
m (cm ) 2940, 2102, 1620,
A stirred solution of 2.5 g of 9-O-mesylquinidine (6.2 mmol,
1
equiv) in 12 ml of anhydrous DMF was treated with 0.6 g of
[a
]
D
3
NaN (9.23 mmol, 1.5 equiv). The mixture was stirred on oil bath
3
at 45–55 °C until all the mesylate was consumed (12–48 h, TLC
monitoring), after which filtration of salts, and evaporation of
DMF under reduced pressure (water bath 50 °C) took place. The
crude azide was dissolved in a small portion of dichloromethane
and purified by liquid chromatography on silica gel using 5% meth-
anol in dichloromethane. Yield: 1.63 g (75%) as yellowish, dense
oil.
4.6. (8S,9S)-9-Azido-(9-deoxy)epiquinine epi-QN-2
1
Method A, yellowish oil, yield 2.53 g (95%), H NMR (CDCl
3
): d
0
0
8.79 (d, 1H, J = 4.5 Hz, H-2 ), 8.09 (d, 1H, J = 9.1 Hz, H-8 ), 7.48 (br,
0
0
1H, H-5 ), 7.43 (dd, 1H, J = 9.1, 2.6 Hz, H-7 ), 7.34 (d, 1H,
0
J = 4.5 Hz, H-3 ), 5.76 (ddd, 1H, J = 17.4, 10.4, 7.4 Hz, H-10), 5.02
(br, 1H, H-9), 5.01 (dt, 1H, J = 17.4, 1.4 Hz, H-11a), 4.98 (dt, 1H,
0
J = 10.4, 1.4 Hz, H-11b), 3.97 (s, 3H, H-11 ), 3.38 (pseudoq, 1H,
4
.3. General procedure for the synthesis of 9-azido-(9-deoxy)-
J = 9.6 Hz, H-8b), 3.22 (m, 1H, H-6a), 3.32 (dd, 1H, J = 14.0,
10.7 Hz, H-2a); 2.91 (m, 1H, H-6b), 2.85 (ddd, 1H, J = 14.0, 4.4,
Cinchona alkaloids by Mitsunobu inversion (Method B)
2
.5 Hz, H-2b), 2.30 (m, 1H, H-3), 1.67 (m, 1H, H-4), 1.59 (m, 2H,
The reaction is preformed under an inert atmosphere. To the
stirred solution of 0.51 g of 9-epi-quinidine (1.57 mmol, 1 equiv)
and 0.62 g of triphenylphosphine (2.36 mmol, 1.5 equiv) in 15 ml
of anhydrous THF cooled on an ice-bath to 0 °C, 0.41 mL of DPPA
H-5a,b), 1.40 (m, 1H, H-7b), 0.78 (ddm, 1H, J = 13.9, 7.7 Hz, H-7a).
1
3
0
0
0
C NMR (CDCl
3
): 158.09 (C-6 ), 147.94 (C-2 ), 145.01 (C-4 ),
0
0
0
141.32 (C-10), 140.36 (C-9 ), 132.08 (C-8 ), 127.55 (C-10 ), 121.82
0
0
0
(C-7 ), 120.89 (br, C-3 ), 114.26 (C-11), 101.60 (C-5 ), 63.67 (br, C-
0
(
1.88 mmol, 1.2 equiv) was added by syringe (or alternatively
9), 59.11 (C-8), 55.99 (C-2), 55.57 (C-11 ), 40.91 (C-6), 39.35 (C-
3
ml of hydrazoic acid ꢂ4%, ꢂ3 mmol in benzene—caution: volatile
3), 27.94 (C-5), 27.18 (C-4), 26.15 (C-7); HRMS (EI) calcd for
ꢁ1
poison) followed by the slow addition of DIAD (0.45 ml, 1.2 equiv).
The solution was left to stir overnight. Solvent was removed on
rotatory evaporator (bath <30 °C) and the residue was purified by
column chromatography on silica gel using 5% MeOH in dichloro-
methane as the solvent. Products in the forms of dense oils were
prepared with yields of 50–60%.
C
20
H
23
N
5
O 349.1903, found 349.1903, IR (KBr)
2100, 1674, 1621, 1590, 1508, 1475, 1432, 1259, 1242, 1228,
1134, 1083, 1032, 918, 853, 831, 755; [ = +77.5 (c 1, CHCl ).
m (cm ) 2942,
a]
D
3
4.7. (8S,9R)-9-Azido-(9-deoxy)quinine QN-2
1
Method B, yellowish oil, yield 50%, H NMR (CDCl
3
): d 8.79 (d,
0
0
4
.4. (8R,9R)-9-Azido-(9-deoxy)epiquinidine epi-QD-2
1H, J = 4.6 Hz, H-2 ), 8.07 (d, 1H, J = 8.6 Hz, H-8 ), 7.41 (dd, 1H,
J = 8.6, 2.7 Hz, H-7 ), 7.39 (d, 1H, J = 4.6 Hz, H-3 ), 7.32 (d, 1H,
J = 2.7 Hz, H-5 ), 5.82 (ddd, 1H, J = 17.5, 10.2, 7.5 Hz, H-10), 5.19
0
0
1
0
0
H NMR (CDCl
3
): d 8.79 (d, 1H, J = 4.3 Hz, H-2 ), 8.07 (d, 1H,
0
0
J = 9.1 Hz, H-8 ), 7.45 (br s, 1H, H-5 ), 7.42 (dd, 1H, J = 9.1, 4.3 Hz,
H-7 ), 7.37 (d, 1H, J = 4.3 Hz, H-3 ), 5.87 (ddd, 1H, J = 17.2, 10.8,
(br d, 1H, J = 7.2 Hz, H-9), 5.01 (dt, 1H, J = 17.5, 1.4 Hz, H-11a),
0
0
0
4.99 (dt, 1H, J = 10.2, 1.4 Hz, H-11b), 3.95 (s, 3H, H-11 ), 3.27 (pseu-
6
.3 Hz, H-10), 5.11 (dt, 1H, J = 10.4, 1.7 Hz, H-11b), 5.10 (dt, 1H,
doq, 1H, J = 7.4 Hz, H-8b), 3.12 (m, 1H, H-6a), 3.06 (dd, 1H, J = 13.5,
9.9 Hz, H-2b); 2.64 (m, 2H, H-2a, H-6b), 2.27 (br m, 1H, H-3), 1.90
(m, 1H, H-7b), 1.86 (m, 1H, H-4), 1.70 (m, 1H, H-5a), 1.57 (ddm, 1H,
0
J = 17.2, 1.7 Hz, H-11a), 5.08 (br, 1 H, H-9), 3.97 (s, 3H, H-11 ),
3
.26 (pseudoq, 1H, J = 9.3 Hz, H-8a), 3.15 (dd, 1H, J = 14.5, 10.4 Hz,
H-2b), 3.07 (dd, 1H, J = 13.5, 2.4 Hz, H-6a), 3.01 (ddd, 1H, J = 13.5,
.6, 7.9 Hz, H-6b), 2.94 (dd, 1H, J = 14.5, 7.6, 2.1 Hz, H-2a), 2.32
m, 1H, H-3), 1.65 (m, 1H, H-4), 1.55 (m, 2H, H-5a,b), 1.13 (ddd,
1
3
J = 13.6, 7.8 Hz, H-7a), 1.53 (m, 1H, H-5b). C NMR (CDCl
3
): 158.04
0
0
0
0
9
(
(C-6 ), 147.48 (C-2 ), 144.83 (C-4 ), 141.82 (C-9 ), 141.50 (C-10),
0
0
0
0
131.99 (C-8 ), 127.03 (C-10 ), 121.65 (C-7 ), 119.46 (C-3 ), 114.49
13
0
1
H, J = 13.8, 8.8, 1.8 Hz, H-7b), 0.94 (m, 1H, H-7a). C NMR
(C-11), 101.04 (C-5 ), 65.28 (br, C-9), 58.41 (C-8), 56.48 (C-2),
0
0
0
0
0
(
CDCl
3
): 158.11 (C-6 ), 147.46 (C-2 ), 144.98 (C-4 ), 140.92 (C-9 ),
55.59 (C-11 ), 41.98 (C-6), 39.48 (C-3), 27.59 (C-5), 27.50 (C-4),
0
0
0
1
40.34 (C-10), 132.09 (C-8 ), 127.54 (C-10 ), 122.08 (C-7 ), 120.71
24.93 (C-7).HRMS (EI) calcd for C20
H
23
N
5
O 349.1903, found
0
0
ꢁ1
(
br, C-3 ), 114.77 (C-11), 101.29 (C-5 ), 62.40 (br, C-9), 59.85 (br,
349.1893, IR (KBr)
m
(cm ) 2941, 2103, 1724, 1621, 1590, 1508,
0
C-8), 55.57 (C-11 ), 49.34 (C-6), 47.39 (C-2), 39.18 (C-3), 27.19
1473, 1455, 1432, 1256, 1242, 1228, 1132, 1084, 1031, 989, 912,
(
3
1
C-4), 26.41 (C-5), 25.14 (C-7); HRMS (EI) calcd for C20
H
23
N
5
O
852, 832, 737; [ ).
a
]
D
= ꢁ28.2 (c 1.1, CHCl
3
ꢁ1
49.1903, found 349.1894, IR (KBr)
621, 1508, 1475, 1433, 1258, 1227, 1137, 1090, 1030, 852, 828;
= +55.7 (c 1, CHCl ).
m (cm ) 2938, 2100, 1675,
4.8. QD-3 (triazoline)
[a
]
D
3
1
0
H NMR (DMSO-d
6
): d 8.77 (d, 1H, J = 4.6 Hz, H-2 ), 8.02 (d, 1H,
0
0
4
.5. (8R,9S)-9-Azido-(9-deoxy)quinidine QD-2
J = 9.2 Hz, H-8 ), 7.59 (d, 1H, J = 4.6 Hz, H-3 ), 7.47 (dd, 1H, J = 9.2,
.7 Hz, H-7 ), 7.27 (d, 1H, J = 2.7 Hz, H-5 ), 6.34 (s, 1H, H-9), 4.49
0
0
2
1
Method B, yellowish oil, 300 mg (55%), H NMR (CDCl
3
): d 8.79
(dd, 1H, J = 20.8, 13.5 Hz, H-11b), 4.48 (m, 1H, H-10), 4.11 (dd,
1H, J = 20.8, 12.8 Hz, H-11a), 3.94 (s, 3H, H-11 ), 3.35 (d, 1H,
0
0
0
(
d, 1H, J = 4.4 Hz, H-2 ), 8.06 (d, 1H, J = 9.2 Hz, H-8 ), 7.40 (dd, 1H,